Related references
Note: Only part of the references are listed.Risk factors associated with the isolation of colistin-resistant Gyam-negative bacteria: A matched case-control study
Dimitrios K. Matthaiou et al.
CRITICAL CARE MEDICINE (2008)
Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin
Miruna D. David et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance:: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
Phillip J. Bergen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: A prospective study
Argyris Michalopoulos et al.
RESPIRATORY MEDICINE (2008)
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
M. Bassetti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy
Joshua S. Hawley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome
Karen S. McCoy
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections:: a matched case-control study
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains
Jerome R. Lo-Ten-Foe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand
Pornpan Koomanachai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2007)
Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro Pharmacokinetic/Pharmacodynamic model
Chun-Hong Tan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa
Spyros D. Mentzelopoulos et al.
INTENSIVE CARE MEDICINE (2007)
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
F. G. Rios et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study
H. Kallel et al.
INTENSIVE CARE MEDICINE (2007)
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain
Oscar Cirioni et al.
CRITICAL CARE MEDICINE (2007)
Infectious complications of monoclonal antibodies used in cancer therapy - A systematic review of the evidence from randomized controlled trials
Petros I. Rafailidis et al.
CANCER (2007)
Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients
Ray Y. Hachem et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
When to include polymyxins, in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approach
Matthew E. Falagas et al.
SHOCK (2007)
Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population
Jeremy Goverman et al.
JOURNAL OF BURN CARE & RESEARCH (2007)
Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin
F. W. Goldstein et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients:: first report of a multiclonal cluster
Anastasia Antoniadou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Roxanne J. Owen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Colistin and rhabdomyolysis: A causative agent or an innocent bystander?
Penelope Evagelopoulou et al.
INTENSIVE CARE MEDICINE (2007)
Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin
Alkistis Pantopoulou et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis
C. Tascini et al.
JOURNAL OF CHEMOTHERAPY (2006)
Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections
M. E. Falagas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin:: case series and literature review
John Ng et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU
Hatem Kallel et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Occurrence of carbapenern-resistant Acinetobacter baumannii clones at multiple hospitals in London and southeast England
Juliana M. Coelho et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria
M. E. Falagas et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
Jian Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
F Ratjen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically III Patients: A Review of the Recent Literature
Matthew E. Falagas et al.
CLINICAL MEDICINE & RESEARCH (2006)
Polymyxins: A word of caution for prudent use of valuable Old antibiotics
Matthew E. Falagas et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
Nephrotoxicity of intravenous colistin: a prospective evaluation
ME Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections:: a prospective cohort study
R Reina et al.
INTENSIVE CARE MEDICINE (2005)
Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections:: clinical outcome and adverse events
N Petrosillo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis
SK Kasiakou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan
PR Hsueh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Effect of aminoglycoside and β-lactam combination therapy versus β-lactam monotherapy on the emergence of antimicrobial resistance:: A meta-analysis of randomized, controlled trials
IA Bliziotis et al.
CLINICAL INFECTIOUS DISEASES (2005)
Cure of post-traumatic recurrent multiresistant gram-negative rod meningitis with intraventricular colistin
SK Kasiakou et al.
JOURNAL OF INFECTION (2005)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
ME Falagas et al.
BMC INFECTIOUS DISEASES (2005)
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
A Michalopoulos et al.
CRITICAL CARE (2005)
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic
AS Michalopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Bronchial constriction and inhaled colistin in cystic fibrosis
GA Alothman et al.
CHEST (2005)
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
ME Falagas et al.
BMC INFECTIOUS DISEASES (2005)
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
N Markou et al.
CRITICAL CARE (2003)
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin:: A comparison with imipenem-susceptible VAP
J Garnacho-Montero et al.
CLINICAL INFECTIOUS DISEASES (2003)
Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis
J Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa
PK Linden et al.
CLINICAL INFECTIOUS DISEASES (2003)
Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii
EJ Giamarellos-Bourboulis et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2001)
Share Paper
